Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alivisatos appointed Samsung Distinguished Chair in Nanoscience

Published: Friday, August 23, 2013
Last Updated: Friday, August 23, 2013
Bookmark and Share
Chemist Paul Alivisatos awarded appointment UC Berkeley in recognition of his many scientific achievements.

The endowed chair, established through the support of Samsung Electronics Co., will help cement the campus’s leadership in research and innovation in an area that has great implications for many fields ranging from biology to energy, the Office of the Vice-Chancellor for Research announced Thursday (Aug. 22). Alivisatos, director of the Lawrence Berkeley National Laboratory and a UC Berkeley professor of chemistry, is known for his research into quantum dot semiconductor nanocrystals, clusters of hundreds to thousands of atoms with novel properties that can be applied to electronic devices and solar cells as well as light-emitting diodes (LEDs).

Dr. Youngjoon Gil, executive vice president of the Samsung Advanced Institute of Technology, welcomed the appointment.

“Historically, the invention of a new material can initiate a quantum leap in the development of industry,” said Dr. Gil. “Nanomaterials offer such opportunities for the electronics as well as the biosciences industry, where precise control and manipulation of energy is required. Quantum dot, pioneered by Professor Alivisatos, has established its commercial value by reproducing more realistic colors on displays. Through the establishment of the endowed chair, Samsung anticipates a closer partnership with UC Berkeley, the world’s leader in nanoscience, in exploring the commercial value of nanotechnology.”

Over the past two decades, UC Berkeley has become a brain trust in nanoscience and nanotechnology, with nearly a hundred nanoscience and nanotech researchers in the fields of biology, chemistry, physics and materials science. These researchers have made major advances in understanding the nano-scale molecular motors that move materials around inside cells or manipulate DNA; creating tiny motors, lasers and photonic devices for smaller electronic circuits; creating flexible and inexpensive solar cells from nanorods; and understanding the properties of new materials such as graphene and high-temperature superconductors.

Graham Fleming, UC Berkeley’s vice chancellor for research, lauded Samsung for its initiative in establishing this chair.

“The new chair helps build on our strengths in the conversation and utilization of energy on the nano scale,” said Fleming. “It is a fitting recognition of Paul’s achievements and his world-wide influence on the field of nanoscience. We look forward to continue expanding our relationship with Samsung in this area.”

Alivisatos is widely recognized for his contributions to the study of nanocrystals, ranging from control of their synthesis and fabrication to studies of their optical, electrical, structural, and thermodynamic properties. He demonstrated that semiconductor nanocrystals can be grown into rods as opposed to spheres. This achievement paved the way for a slew of new synthetic advances, developing methods for controlling the shape, connectivity and topology of nanocrystals.

Nanocrystals are typically a few nanometers in diameter — larger than molecules but smaller than bulk solids — and frequently exhibit physical and chemical properties somewhere in between. Given that a nanocrystal is virtually all surface and no interior, its properties can vary considerably as the crystal grows.

Alivisatos’s research has opened the door to a number of potential new applications for nanocrystals. These include their use as fluorescent probes for the study of biological materials and LEDs, and the fabrication of hybrid solar cells that combine nanotechnology with plastic electronics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!